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Abstract
Objectives: A national survey in 1997 demonstrated that trachoma was endemic in Mali. Interventions to control trachoma
including mass drug administration (MDA) with azithromycin were launched in the regions of Kayes and Koulikoro in 2003.
MDA was discontinued after three annual rounds in 2006, and an impact survey conducted. We resurveyed all districts in
Kayes and Koulikoro in 2009 to reassess trachoma prevalence and determine intervention objectives for the future. In this
paper we present findings from both the 2006 and 2009 surveys.
Methods: Population-based cluster surveys were conducted in each of the nine districts in Koulikoro in 2006 and 2009,
whilst in Kayes, four of seven districts in 2006 and all seven districts in 2009 were surveyed. Household members present
were examined for clinical signs of trachoma.
Results: Overall, 29,179 persons from 2,528 compounds, in 260 clusters were examined in 2006 and 32,918 from 7,533
households in 320 clusters in 2009. The prevalence of TF in children aged 1–9 years in Kayes and Koulikoro was 3.9% (95%CI
2.9–5.0%, range by district 1.2–5.4%) and 2.7% (95%CI 2.3–3.1%, range by district 0.1–5.0%) respectively in 2006. In 2009 TF
prevalence was 7.26% (95%CI 6.2–8.2%, range by district 2.5–15.4%) in Kayes and 8.19% (95%CI 7.3–9.1%, range by district
1.7–17.2%) in Koulikoro among children of the same age group. TT in adults 15 years of age and older was 2.37% (95%CI
1.66–3.07%, range by district 0.30–3.54%) in 2006 and 1.37% (95%CI 1.02–1.72%, range by district 0.37–1.87%) in 2009 in
Kayes and 1.75% (95%CI 1.31–2.23%, range by district 1.06–2.49%) in 2006 and 1.08% (95%CI 0.86–1.30%, range by district
0.34–1.78%) in 2009 in Koulikoro.
Conclusions: Using WHO guidelines for decision making, four districts, Bafoulabe in Kayes Region; and Banamba, Kolokani
and Koulikoro in Koulikoro Region, still meet criteria for district-wide implementation of the full SAFE strategy as TF in
children exceeds 10%. A community-by-community approach to trachoma control may now be required in the other twelve
districts. Trichiasis surgery provision remains a need in all districts and should be enhanced in six districts in Kayes and five
in Koulikoro where the prevalence exceeded 1.0% in adults. Since 1997 great progress has been observed in the fight
against blinding trachoma; however, greater effort is required to meet the elimination target of 2015.
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Introduction
Trachoma, a blinding bacterial disease of the conjunctiva, is
targeted for elimination as a public health problem by the year
2020, yet an estimated 8.2 million people remain at immediate risk
of blindness or visual impairment due to the disease [1]. To
achieve the elimination target, the World Health Organization
(WHO) recommends member states implement an integrated
strategy of interventions known as SAFE: surgery to correct
trachomatous trichiasis; mass administration of antibiotics to treat
current trachoma infections and reduce the infectious reservoir;
promotion of hygiene and facial cleanliness; and water and
sanitation as environmental improvements aimed at interrupting
transmission of the infection. Based on WHO guidelines, districts
are categorized for intervention based on the prevalence of clinical
signs of disease: trachomatous inflammation follicular (TF) in
children aged 1–9 years and trachomatous trichiasis (TT) in adults
aged 15 years and older [2,3].
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National Blindness Prevention Program in Mali initiated a
trachoma control program. Mapping of trachoma in Mali
identified trachoma to be of public health significance throughout
the country, including the regions of Kayes and Koulikoro where
the prevalence of TF in children less than 10 years of age was
42.5% and 33.5% respectively [4]. The highest levels of TT
among women 15 years of age and older were observed in Kayes
(3.3%) and Koulikoro (3.9%) [4]. From 2002 to 2006 all sixteen
districts in Kayes and Koulikoro received SAFE interventions to
control trachoma. The interventions implemented in each region
are listed in Table 1. Interventions were conducted in several
ways: trained ophthalmic nurses moved from village to village
offering free trichiasis surgery; mass distribution of oral azithro-
mycin and tetracycline ophthalmic ointment occurred in annual
campaigns for three consecutive years in each district following
pilot distributions in target areas; facial hygiene, latrine construc-
tion and use, and the utilization of water for hygiene were
promoted over local and regional radio stations; and persons in
each region were trained to deliver health education and promote
behavior change. The number of doses distributed and population
coverage with azithromycin by district and year is shown in
Table 2. In 2006, after three years of intervention and in
accordance with the WHO guidelines, an impact evaluation was
conducted to assess the effect of the SAFE activities [2]. The
Ministry of Health withdrew A, and support for F and E
interventions from partner organizations was limited. The
Ministry of Health concentrated efforts to scale up the SAFE
strategy in other regions yet to initiate interventions. The purpose
of this study was to re-evaluate the prevalence of trachoma three
years after SAFE interventions were discontinued in Kayes and
Koulikoro. Here we present the data from the first impact
evaluation in 2006 and the recent 2009 evaluation. We also aimed
to quantify any need for additional interventions.
Methods
Ethical considerations
These prevalence surveys were conducted in accordance with
WHO guidelines as part of the ongoing effort of the Ministry of
Health to eliminate blinding trachoma in Mali and were necessary
to evaluate the impact of interventions. In addition to the Ministry
of Health, the survey protocol was approved by the Emory
University IRB under protocol 079-2006. Informed verbal consent
and assent was received according to the principles of the
Declaration of Helsinki. Written consent was not obtained in
these surveys due to the low literacy rate, ranging from 3% in rural
Mali to 38% in Bamako (Enque ˆte De ´mographique et de Sante ´
2001). Emory University IRB approved the use of informed verbal
consent. Oral informed consent was sought first from village chiefs
before surveys were conducted in the randomly selected villages.
Author Summary
Trachoma, a blinding bacterial disease, is targeted for
elimination by 2020. To achieve the elimination target, the
World Health Organization (WHO) recommends member
states implement the SAFE strategy; surgery, mass
administration of antibiotics, promotion of hygiene and
facial cleanliness and water and sanitation as environmen-
tal improvements. We present results from evaluation
surveys conducted in 2006 and 2009 from the regions of
Kayes and Koulikoro, Mali. Prevalence of active trachoma in
2006 was below baseline intervention thresholds in all
surveyed districts and the national program stopped
antibiotic distribution. The prevalence of trachoma in
2009 remained well below levels in 1998. However, in 8 of
13 districts compared, the prevalence of active trachoma
was higher in 2009 than 2006. Three years of antibiotic
intervention did not equate in all districts to a sustained
reduction of active trachoma. No surveillance activities
were implemented after stopping interventions. Surgical
interventions may have reduced the burden of blinding
trachoma but there is an ongoing need for surgeries
specifically targeting affected women. Four districts meet
the WHO criteria for resuming district-wide mass antibiotic
distribution. A community-by-community approach to
elimination may be needed in other districts. The
promotion of facial cleanliness and good hygiene behavior
should be reintroduced.
Table 1. SAFE Interventions in Kayes and Koulikoro Regions of Mali 2002–2006
+.
Kayes Koulikoro
Surgery 15 Ophthalmic Technicians trained to perform trichiasis surgery
3 371 persons operated*
10 Ophthalmic Technicians trained to perform trichiasis
surgery
4 651 persons operated*
Antibiotic Mass distribution of azithromycin
3 079 437 doses distributed
Average coverage
{ of total population
Range by district 54.9–77.7%
(see Table 2)
Mass distribution of azithromycin
3 744 688 doses distributed
Average coverage
{ of total population
Range by district 43.9–86.1%
(see Table 2)
Facial Hygiene 18 Local Non-Government Organizations trained in trachoma
Information, Education and Communication (IEC)
16 community radio stations commissioned to broadcast IEC
messages
3 219 community IEC agents trained
27 community radio stations commissioned to broadcast
IEC messages
Environmental Improvements 81 wells were rehabilitated
2 190 household latrines were constructed
75 community hygiene and sanitation committees were
formed
35 water point management committees were formed
+Interventions are those performed by, or reported to the Programme National de Lutte contre la Ce ´cite ´ and do not include any other activities not targeted to
trachoma control.
*Cumulative number of persons operated to correct trichiasis from 2002–2008.
{3-year average coverage defined as: reported total number doses distributed divided by the census estimate for total population.
doi:10.1371/journal.pntd.0000734.t001
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selected households and finally oral consent was obtained from
each adult examined and consent from a parent or caretaker was
obtained to examine children. Verbal assent was obtained also
from children 6–14 years of age. Survey participants were
informed of the purpose of the trachoma examinations and their
rights not to participate or to stop the examination at any time.
Choosing not to participate did not affect any decision in
determining the need for interventions. Verbal consent was
documented on a standard survey data collection tool. All children
presenting signs of TF or trachomatous inflammation intense (TI)
were offered free tetracycline eye ointment and instructed to apply
it twice daily for 6 weeks. Persons identified with TT were
recorded, counseled, and offered free consultation and surgery
with a trained TT surgeon.
Survey setting
Kayes Region is located in the extreme west of Mali bordering
Mauritania to the north, Senegal to the west, and Guinea to the
southwest (Figure 1). The region is divided into seven health
districts with an estimated combined population of 1,763,987
persons (Mali National Demographic and Statistical Institute 2009
population projection). The primary ethnic groups are the
Sarakole (Soninke) and Bambara.
Koulikoro Region is located in the western interior of Mali
directly east of Kayes Region. It also borders Mauritania to the
north and Guinea to the southwest. Koulikoro is divided into nine
health districts with an estimated population of 2,072,185 persons
(Mali National Demographic and Statistical Institute 2009
population projection). The primary ethnic groups are the
Bambara and Malinke.
Design/sampling
In both 2006 and 2009, population-based cross-sectional
household surveys were conducted at the district level. Each
survey in 2006 was done at least 6 months after the last round of
antibiotic distribution following the implementation plan of the
national program. Thus some districts in Kayes and Koulikoro
were surveyed during the period between March and May and
some during November and December. In 2009, all districts were
surveyed during the period between March and May. Twenty
villages (clusters) were selected from each district with a probability
of selection proportional to the total population of the village. All
villages with less than 5,000 total population from each district
were eligible for selection. In 2006, 4 of 7 districts in Kayes
(Bafoulabe, Diema, Kita and Nioro du Sahel) and all 9 districts in
Koulikoro were assessed. In each of these districts, concessions
(household compounds) were systematically selected using the
random direction method [5]. All residents aged 1–9 years of age
and 15 years of age and older from all households within selected
concessions were examined for clinical signs of trachoma until
approximately 60 qualifying children had been examined. In
2009, all 16 districts in the two regions were surveyed for a total of
320 clusters. Households within a cluster were randomly selected
following the method of sketch mapping and segmentation which
aimed to survey 24 households per cluster [6]. With the assistance
of village leaders, survey teams drafted a list of all households,
dividing households into segments of four. Village chiefs selected
segments via lottery. All households in a selected segment were
surveyed and all consenting persons over six months of age in each
household were examined for trachoma. From the sampling
methodology used in both surveys we assumed that the data was
self-weighted.
Table 2. District level antibiotic coverage of the total population in Kayes and Koulikoro Regions of Mali based on reported doses
of azithromycin distributed
{ from 2002–2006.
District
2006 Estimated
total population
Round 1 Doses
distributed
(% Coverage)
Round 2 Doses
distributed
(% Coverage)
Round 3 Doses
distributed
(% Coverage)
3-year average %
coverage
Kayes
1. Bafoulabe ´ 205 228 93 542 (45.6) 42 823 (20.9) 201 749 (98.3) 54.9
2. Die ´ma 172 599 82 813 (48.0) 180 949 (104.8) 111 623 (64.7) 72.5
3. Kayes 390 223 165 933 (42.5) 327 820 (84.0) 158 421 (40.6) 55.7
4. Ke ´nie ´ba 182 897 78 590 (43.0) 184 301 (100.8) 147 451 (80.6) 74.8
5. Kita 361 370 191 667(53.0) 86 556 (24.0) 330 646 (91.5) 56.2
6. Nioro du Sahel 201 551 94 213 (46.7) 204 907 (101.7) 170 783 (84.7) 77.7
7. Yelimane 147 735 59 629 (40.4) 142 058 (96.2) 84 704 (57.3) 64.6
Koulikoro
8. Banamba 220 055 94 206 (42.8) 69 143 (31.4) 126 688 (57.6) 43.9
9. Dioila 212 977 139 255 (65.4) 120 735 (56.7) 226 582 (106.4) 76.2
10. Fana 199 487 150 640 (75.5) 118 401 (59.4) 119 205 (59.8) 64.9
11. Kangaba 90 928 65 680 (72.2) 70 385 (77.4) 98 787 (108.6) 86.1
12. Kati 611 471 273 605 (44.7) 365 552 (59.8) 341 688 (55.9) 53.5
13. Kolokani 215 270 76 105 (35.4) 174 880 (81.2) 90 694 (42.1) 52.9
14. Koulikoro 182 662 125 035 (68.5) 151 717 (83.1) 142 441 (78.0) 76.5
15. Nara 198 488 97 769 (49.3) 145 557 (73.3) 164 778 (83.0) 68.5
16. Ouelessebougou 169 185 62 022 (36.7) 115 935 (68.5) 109 352 (64.6) 56.6
{Distributed is defined as the total number of doses reported distributed by the district health facilities during mass drug administration campaigns.
doi:10.1371/journal.pntd.0000734.t002
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Residents of selected households in 2009 were enumerated and
designated as either present or absent. Absent was defined as not
being physically present in the village on the day of the survey.
Enumerated persons who were not at home, but in the village were
found and recruited to the survey. Teams made at least one
attempt on the same day to find residents marked absent during
the first visit to the household. Absent residents in the 2006 survey
were not enumerated. Clinical signs of trachoma were assessed
using the WHO Simplified Grading System [3]. Examiners
recorded the presence or absence of all trachoma grades in both
eyes of survey participants using a 62.5 binocular loupe and
adequate light. The findings from the worst affected eye were
reported. At examination in 2009, children were assessed for a
clean face, defined as the absence of both ocular and nasal
discharge. In 2009, each child 6–15 years of age was asked about
their attendance in school, defined as public or private non-
religious school. Attendance of Koranic schools or non-formal
education was not assessed. Examined persons were asked about
their participation in the most recent round of antibiotic
distribution for trachoma control, defined as whether a person
took oral azithromycin, applied tetracycline eye ointment, or did
not participate. Estimates for participation in antibiotic distribu-
tion included only those persons present to give a response.
Additionally in 2009, one adult respondent was interviewed in
each household to determine the presence and use of a household
latrine and the location of the main water source used by the
household. The presence of a latrine was confirmed by direct
observation and ‘use’ was defined as the observation of feces in the
pit. The location of the water source was designated as within the
household compound, within the village, or outside the geograph-
ical village boundaries as a proxy for distance and availability of
water. Household interviews were not conducted in the 2006
surveys.
Quality control and data management
Prior to the surveys, ophthalmic nurses were trained to use the
WHO Simplified Trachoma Grading System through repetitive
grading of digital photographs in a classroom setting and
assessment of individual patients in the field. In 2009, these
exercises were followed by a formal inter-observer reliability test of
trachoma grading against a standardized set of 50 slides presented
on a computer and a field exam of 50 children in which SB, DS
and JDK were considered the reference examiners. Reference
grading was supplemented with digital photographs. Eight out of
ten ophthalmic nurses met the criteria of achieving greater than
80% reliability and a kappa statistic of 0.6 and above for grade TF
and were selected as examiners for the survey. Survey teams were
trained to randomly select households within a cluster, conduct
household interviews, and record findings on standardized forms.
Figure 1. Regions of Kayes and Koulikoro, Mali.
doi:10.1371/journal.pntd.0000734.g001
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nurse. Formal inter-observer reliability tests were not conducted
for the examiners in 2006.
Data were double-entered, compared and corrected. Based on
the survey design used, we adjusted confidence intervals for the
prevalence estimates and odds ratios to account for correlation
among the data due to clustering using SAS SURVEY procedures
(SAS version 9.2, SAS Institute Inc) [7,8]. Regional prevalence
estimates accounted for population differences between districts.
We calculated differences between prevalence estimates from 2006
and 2009 and tested the equality of the estimates using the Z
statistic with a=0.05.
Quantification of SAFE interventions
The ultimate intervention goal considered for achieving
blinding trachoma elimination is the presence of less than 1 TT
case per 1,000 population [9]. We calculated the total backlog of
persons with TT in need of surgery by multiplying the 2009 point
estimate and confidence limits of the population prevalence of TT
by the estimated total population to give a point estimate and
lower and upper bounds of the total number of people to be
operated. According to WHO guidelines, where district-level
prevalence of TF in 1–9 year-old children exceeds 10% at
baseline, A, F and E activities are warranted district-wide and thus
the total population living in these areas is targeted [2]. Where
SAFE activities have been implemented, all areas that remain
above 5% TF prevalence among children should continue
antibiotic distribution [2]. The target prevalence by which mass
antibiotic interventions to control trachoma is not needed is below
5% TF [2]. We calculated the number of household latrines
required to achieve goal 7c of the United Nations Millennium
Development Goals (MDGs); halve by 2015 the proportion of
people who do not have access to improved sanitation [10].
Results
Surveys in 2006
In 2006, a total of 29,179 persons were examined from 29,779
persons available in 2 528 selected concessions. The mean number
of concessions per district was 194.5 with a range by district of 110
to 312 concessions. A mean of 9.7 concessions were surveyed per
village (range by village 1–25). The mean number of households
per concession was 1.9 (range by concession 1–17). In the four
surveyed districts of Kayes, 4,168 adults over 14 years of age and
4,808 children 1–9 years of age were examined for clinical signs of
trachoma. In Koulikoro, 9,679 adults and 10,524 children were
examined. Among examined adults over 14 years of age, 68.9%
were women and among examined children 1–9 years of age,
51.5% were girls.
Clinical observations
The prevalence estimates of clinical signs of trachoma in Kayes
and Koulikoro in 2006 are presented in the first three columns by
district in Table 3. Among adults 15 years of age and older, the
prevalence of TT in Kayes was 2.37% (95%CI 1.66–3.07%, range
by district 0.30–3.54%) and in Koulikoro, 1.75% (95%CI 1.31–
2.23%, range by district 1.06–2.49%). The prevalence of
trachomatous scaring (TS) among adults was 10.33% (95%CI
8.6–12.0%, range by district 3.0–18.4%) and 4.18% (95%CI 3.5–
4.8%, range by district 0.6%–9.2%) in Kayes and Koulikoro
respectively (data not shown). Prevalence of trachomatous corneal
opacity (CO) in Kayes was 0.38% (95%CI 0.14–0.61, range by
district 0.0–0.9%) and 0.31% (95%CI 0.12–0.51%, range by
district 0.0–0.9%) in Koulikoro. Women were more likely than
men to have TT (OR=1.61, 95%CI 1.16–2.23, p=0.004). Adults
50 years and older were more likely to have TT than adults aged
15–49 years (OR=6.73, 95%CI 4.99–9.07, p=,0.0001).
District-level prevalence of TF among children 1–9 years of age
had reduced to below the 10% intervention threshold in all
surveyed districts. Among children 1–9 years of age, the
prevalence of TF was 3.9% (95%CI 2.9–5.0%, range by district
1.2–5.4%) in Kayes and 2.7% (95%CI 2.3–3.1%, range by district
0.1–5.6%) in Koulikoro. The prevalence of trachomatous
inflammation intense (TI) among children aged 1–9 years of age
was 1.0% (95% CI 0.6–1.5%, range by district 0.3–1.8%) in Kayes
and 0.4% (95% CI 0.2–0.5%, range by district 0–2.0%) in
Koulikoro. Active trachoma (TF and/or TI) prevalence was
4.53% (95%CI 3.3–5.7%, range by district 1.2–6.5%) in Kayes
and 2.96% (95%CI 2.5–3.4%, range by district 0.2–5.6%) in
Koulikoro.
Surveys in 2009
In 2009, from all districts in both regions a total of 42,128
persons were enumerated in 7,533 households and 32,918 were
examined. In Kayes, a total of 13,576 persons were examined for
signs of trachoma out of 17,127 persons enumerated from 3,287
households for a response rate of 79.3%. In Koulikoro, 19,342
persons were examined out of 25,001 persons enumerated from
4,246 households (a response rate of 77.4%). The response rate in
women was 83.1% (17,771/21,386) and 73.0% (15,147/20,742) in
men. The majority of adult men unable to be examined were
absent from the home at the time of the household visit. Children
1–9 years of age composed 33.9% of the total enumerated
population. Adults 15 years of age and older were 51.0% of the
total population. The proportion of enumerated children 1–9
years of age who were examined was 88.2% and 77.1% of
enumerated adults were examined. Among examined adults over
14 years of age, 58.1% were women and among examined
children 1–9 years of age, 49.7% were girls. Among children 6–15
years of age the proportion that reported attending school was
42.6% in Kayes and 54.1% in Koulikoro.
Clinical observations
The prevalence estimates of clinical signs of trachoma in Kayes
and Koulikoro for 2009 are presented by district in the last four
columns of Table 3. The prevalence of TT in the total population
of Kayes region was 0.69% (95%CI 0.53–0.85%, range by district
0.20–0.91%). In Koulikoro, TT prevalence in the total population
was 0.56% (95%CI 0.43–0.69%, range by district 0.25–0.85%).
Among adults 15 years of age and older, the prevalence of TT in
Kayes was 1.45% (95%CI 1.10–1.79%, range by district 0.37–
1.87%) and in Koulikoro, 1.10% (95%CI 0.84–1.35%, range by
district 0.34–1.78%). The prevalence of trachomatous scaring (TS)
among adults was 4.22% (95%CI 3.7–4.8%, range by district 0.3–
5.3%) and 4.68% (95%CI 4.1–5.2%, range by district 1.4–8.1%)
in Kayes and Koulikoro, respectively (data not shown). Prevalence
of CO in Kayes was 0.11% (95%CI 0.03–0.19, range by district
0–0.42%) and 0.21% (95%CI 0.13–0.29%, range by district
0–0.73%) in Koulikoro. Odds of TT among adults 50 years of age
and older were ten times higher than adults 15–49 years of age
(OR=10.61, 95%CI 7.62–14.78, p,0.0001). Women were nearly
two times more likely to have TT than men (OR=1.85, 95%CI
1.40–2.46, p,0.0001).
At the regional level, the prevalence of TF was 6.6% (95%CI
5.7–7.5%, range by district 2.5–15.4%) among children 1–9 years
of age in Kayes and 8.7% (95%CI 7.5–9.9%, range by district 1.7–
17.2%) in Koulikoro. The prevalence of TI among children aged
1–9 years of age was 1.5% (95% CI 1.1–1.8%, range by district
Trachoma Prevalence in Kayes and Koulikoro, Mali
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0–1.9%) in Koulikoro. Active trachoma (TF and/or TI)
prevalence was 7.34% (95%CI 6.4–8.3%, range by district 2.7–
16.8%) in Kayes and 8.91% (95%CI 7.7–10.1%, range by district
2.0–17.9%) in Koulikoro.
Characteristics associated with uptake of SAFE strategy
2009
A total of 7,533 households were surveyed (range by district
423–480). The mean number of persons living in each household
was 5.2 (SD=2.7, range by district 4.5–5.9) in Kayes and 5.9
(SD=3.0, range by district 4.9–6.9) in Koulikoro. Indicators of
uptake of the A, F and E components of the SAFE strategy are
listed by district in Table 4. The proportion of examined
household residents reporting taking azithromycin or using
tetracycline eye ointment in the most recent round of distribution
was 86.1% (95%CI 84.2–88.0, range by district 54.6–99.8%) in
Kayes and 83.9% (95%CI 81.6–86.3%, range by district 59.9–
96.8%) in Koulikoro. Among children 1–9 years of age, 76.5%
(95%CI 74.3–78.7%, range by district 46.7–95.2%) and 75.0%
(95%CI 71.8–78.1%, range by district 52.1–86.8%) in Kayes and
Koulikoro, respectively, had a clean face at examination. Basic
sanitation (a household latrine) was evident in over 80% of the
households in 12 out of the 16 districts. The presence of a latrine
with evidence of use was observed in 88.1% (95% CI 85.2–91.1%,
range by district 50.4–100%) of surveyed households in Kayes and
87.2% (95%CI 84.5–89.9%, range by district 37.4–99.8%) in
Koulikoro. A water source inside the compound was observed in
9.7% (95%CI 5.5–13.9%, range by district 0.6–17.2%) of
surveyed households in Kayes and 3.2% (95%CI 0.5–6.0%, range
by district 0–11.8%) reported having to travel outside the
geographical boundaries of the village to collect water. In
Koulikoro, 19.8% (95%CI 15.6–24.0%, range by district 0–
31.9%) of households had a source of water within the compound
and 5.6% (95%CI 3.5–7.7%, range by district 0–17.2%) reported
having to collect water from a source outside of village boundaries.
Overall, there was no difference in the prevalence of clean faces
between children living in households with water access inside the
compound and children in households where the water source was
outside the compound; 76.3% compared to 75.7%, Z=0.48,
p=0.633.
Difference between 2006 and 2009 estimates
The regional estimates of prevalence of TT and CO among
women 15 years of age and older from 2006 and 2009 are plotted
in Figure 2 with the same estimates reported in 1997 for a
comparison to baseline prevalence. In this age group, the
difference in prevalence of TT between 2006 and 2009 for Kayes
(Z=21.33, p=0.1829) and Koulikoro (Z=21.78, p=0.0744)
regions was not statistically significant. There was no statistically
significant difference in regional estimates of CO among adult
women from 2006 to 2009 (Kayes Z=21.01, p=0.3117;
Koulikoro Z=20.44, p=0.6626). However, among adults of
both genders, the prevalence of TT in 2009 was less than the
Table 3. Prevalence of clinical signs of trachoma in Kayes and Koulikoro Regions, Mali 2006 and 2009.
2006* 2009
District Adults $15 years Children 1–9 years of age All ages Adults $15 years Children 1–9 years of age
TT TF TI TT TT TF TI
Kayes n=4,168 n=4,808 N=13,576 n=6,566 n=5,040
1. Bafoulabe ´ 2.13 (1.1–3.1) 1.2 (0.1–2.4) - 0.66 (0.29–1.04) 1.37 (0.6–2.1) 15.4 (11.7–19.0) 3.3 (1.7–4.8)
2. Die ´ma 2.53 (1.4–3.6) 5.4 (3.6–7.1) 1.8 (0.7–3.0) 0.91 (0.10–1.71) 1.87 (0.2–3.5) 4.7 (2.0–7.4) 1.3 (0.3–2.4)
3. Kayes {{ { 0.75 (0.42–1.08) 1.69 (0.9–2.5) 5.3 (3.4–7.2) 1.9 (0.9–3.0)
4. Ke ´nie ´ba {{ { 0.78 (0.38–1.16) 1.65 (0.8–2.5) 7.1 (3.5–10.8) 0.3 (0.0–0.7)
5. Kita 3.54 (1.8–5.3) 5.2 (2.7–7.7) 1.6 (0.7–2.5) 0.74 (0.31–1.18) 1.52 (0.6–2.4) 2.5 (0.9–4.1) 0.4 (0.0–0.9)
6. Nioro du Sahel 0.30 (0.0–0.6) 2.8 (0.6–5.1) 0.3 (0.0–0.7) 0.59 (0.09–1.09) 1.26 (0.2–2.3) 8.7 (6.0–11.3) 0.5 (0.0–1.0)
7. Yelimane {{ { 0.20 (0.0–0.45) 0.37 (0.0–0.8) 6.5 (4.8–8.1) 2.9 (1.8–4.1)
Region 2.37 (1.7–3.1) 3.9 (2.9–5.0) 1.0 (0.6–1.5) 0.69 (0.53–0.85) 1.45 (1.1–1.8) 6.6 (5.7–7.5) 1.5 (1.1–1.8)
Koulikoro n=9,679 n=10,524 N=19,342 n=9,471 n=7,139
8. Banamba 1.27 (0.3–2.2) 5.3 (3.5–7.0) - 0.85 (0.48–1.23) 1.78 (1.0–2.5) 17.2 (13.7–20.7) 1.9 (0.9–2.8)
9. Dioila 1.53 (0.5–2.6) 0.6 (0.2–1.1) 0.2 (0.0–0.4) 0.67 (0.32–1.02) 1.25 (0.6–1.9) 7.9 (6.0–9.8) 1.0 (0.1–2.0)
10. Fana 1.32 (0.5–2.1) 2.3 (1.2–3.4) 0.1 (0.0–0.3) 0.19 (0.01–0.37) 0.34 (0.0–0.7) 3.9 (2.2–5.7) 0.9 (0.1–1.7)
11. Kangaba 1.25 (0.2–2.3) 2.9 (1.7–4.1) 2.0 (1.3–2.7) 0.31 (0.04–0.59) 0.68 (0.1–1.3) 2.1 (0.6–3.5) 0.7 (0.2–1.3)
12. Kati 2.49 (1.0–4.0) 2.3 (1.3–3.3) 0.4 (0.0–0.8) 0.57 (0.20–0.94) 1.07 (0.4–1.8) 8.4 (4.7–12.2) 0.3 (0.0–0.8)
13. Kolokani 2.05 (1.0–3.1) 5.6 (3.9–7.2) 0.7 (0.3–1.0) 0.76 (0.33–1.18) 1.55 (0.7–2.4) 14.1 (9.2–19.0) 0.3 (0.0–0.7)
14. Koulikoro 1.06 (0.2–2.1) 0.1 (0.0–0.3) 0.1 (0.0–0.3) 0.85 (0.41–1.29) 1.61 (0.7–2.5) 11.4 (9.1–13.7) 0.2 (0.0–0.5)
15. Nara 1.65 (0.9–2.4) 3.8 (2.0–5.6) 0.2 (0.0–0.6) 0.25 (0.0–0.54) 0.53 (0.0–1.2) 2.9 (1.5–4.2) -
16. Ouelessebougou 1.09 (0.3–1.9) 1.3 (0.6–1.9) 0.1 (0.0–0.3) 0.26 (0.0–0.54) 0.55 (0.0–1.1) 1.7 (0.8–2.6) 0.3 (0.0–0.7)
Region 1.75 (1.3–2.2) 2.7 (2.3–3.1) 0.4 (0.2–0.5) 0.56 (0.43–0.69) 1.10 (0.8–1.4) 8.7 (7.5–9.9) 0.6 (0.4–0.8)
*Only persons aged under 10 years and 15 years and older were examined.
{Kayes, Ke ´nie ´ba and Yelimane districts were not surveyed in 2006.
-No cases were observed.
Parentheses show 95% confidence intervals.
doi:10.1371/journal.pntd.0000734.t003
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Koulikoro (Z=22.79, p=0.0052). The prevalence of CO among
all adults between 2006 and 2009 did not differ in Kayes
(Z=21.21, p=0.2245) or Koulikoro (Z=20.55, p=0.5838).
The regional prevalence of TF in 2009 was statistically greater
than that observed in 2006 for both regions (Kayes Z=8.13,
p,0.0001; Koulikoro Z=16.20, p,0.0001). The prevalence of
TF for the region in 1997 is plotted with the district level estimates
of TF from 2006 and 2009 in Figure 3. The differences in district
level estimates between 2009 and 2006 with confidence intervals
are listed in Table 5 along with Z statistic and p-values. The
prevalence of TF observed in 2009 was statistically greater than
that observed in 2006 for Bafoulabe, Nioro du Sahel, Banamba,
Dioila, Fana, Kati, Kolokani and Koulikoro districts. The
prevalence of TF in 2009 was the same or less than that observed
in 2006 in the districts of Diema, Kita, Kangaba, Nara and
Ouelessebougou. Regional estimates of TI among children from
1997, 2006 and 2009 are shown in Figure 4. Also for both regions,
the prevalence of TI in this study was greater than that observed in
2006 (Kayes Z=2.06, p=0.0198; Koulikoro Z=1.86,
p=0.0316). The prevalence of TI observed in 2009 was
statistically greater than that observed in 2006 for Bafoulabe,
Banamba, Dioila and Fana districts.
Estimation of targets for continued SAFE interventions
Based on 2009 estimates, the total number of persons with TT
who remain in need of surgery in Kayes is 10 967 (lower and
upper bounds: 7,144 to 14,123) and 10,726 (bounds: 9,932 to
16,487) in Koulikoro. TT prevalence among adults exceeded 1%
in 11 of 16 districts warranting continued, enhanced efforts to
provide surgery to affected patients. While TT surgery may not be
a priority in Yelimane, Fana, Kangaba, Nara and Oulessebougou
where TT among adults is less than 1%, eye care facilities with the
capacity to operate presenting TT cases should exist.
Mass distribution of antibiotics should resume in Bafoulabe,
Banamba, Kolokani and Koulikoro where the prevalence of TF
exceeds 10% among children. Additionally, according to WHO
guidelines, mass distribution of antibiotics should continue in areas
where after three years of intervention, the prevalence of TF
remains greater than 5% among children under 10 years of age
[2]. This would include communities within all of the 12 other
districts of Kayes and Koulikoro. If this WHO guideline is
interpreted at the district level, 10 districts in Kayes and Koulikoro
regions warrant ongoing mass distribution of antibiotics, targeting
a total population of approximately 2,637,492 persons.
The promotion of facial hygiene and environmental improve-
ments should resume in all districts. Access to water within village
boundaries and household latrine coverage was not lacking in
most districts. Fana, Dioila, Yelimane and Nara had the highest
proportion of households reporting having to collect water outside
village boundaries. An estimated 11,526 households in Kayes and
19,718 households in Koulikoro must collect water outside village
boundaries. The construction and maintenance of water points
could be targeted to communities where access to water is lacking.
Kenieba in Kayes and Nara in Koulikoro had the lowest
proportion of households with a latrine. To ensure that every
Table 4. Indicators of A, F and E uptake in Kayes and Koulikoro Regions, Mali 2009.
District
%Residents taking
antibiotics*
%Children 1–9 years of
age with clean face
%Households (HH)
with used latrine
%HH water source
within compound
%HH water
source outside
village
Kayes
1. Bafoulabe ´ 99.8 (99.3–100) 95.2 (92.3–96.6) 100 10.0 (1.0–19.0) 4.4 (0.0–12.3)
2. Die ´ma 83.2 (81.6–84.8) 77.2 (63.8–77.4) 76.5 (61.3–91.7) 0.6 (0.0–1.6) 0.8 (0.0–2.6)
3. Kayes - 94.7 (92.4–96.9) 100 8.3 (0.0–18.6) 5.0 (0.0–15.5)
4. Ke ´nie ´ba 86.9 (84.9–88.9) 78.6 (73.3–84.0) 50.4 (31.8–69.1) 5.4 (0.4–10.4) 4.7 (0.0–11.3)
5. Kita 98.3 (96.6–99.9) 46.7 (39.3–54.1) 94.1(89.7–98.5) 17.0 (1.0–33.0) 0
6. Nioro du Sahel 54.6 (41.1–68.0) 62.5 (55.7–69.4) 78.2(66.7–89.8) 6.4 (0.0–14.4) 0
7. Yelimane 82.5 (80.6–84.3) 75.0 (70.4–79.6) 99.8 (99.4–100) 17.2 (7.5–26.9) 11.8 (3.9–14.3)
Region 86.1 (84.2–88.0) 76.5 (74.3–78.7) 88.1 (85.2–91.1) 9.7 (5.5–13.9) 3.2 (0.5–6.0)
Koulikoro
8. Banamba 92.8 (90.6–95.0) 76.7 (70.8–82.6) 99.8 (99.4–100) 8.3 (0.6–16.1) 2.3 (0.0–7.1)
9. Dioila 93.4 (91.2–95.7) 74.5 (66.7–82.2) 94.8 (89.2–100) 15.5 (6.6–24.5) 11.8 (3.8–19.7)
10. Fana 96.8 (95.3–98.4) 81.6 (72.8–84.9) 97.3 (95.5–99.1) 19.1 (8.3–30.0) 17.2 (13.1–21.3)
11. Kangaba 59.9 (46.3–73.5) 52.1 (45.9–53.5) 86.3 (76.6–96.0) 31.9 (17.9–45.9) 0.4 (0.0–1.3)
12. Kati 78.0 (70.5–85.6) 75.0 (63.7–86.2) 87.6 (80.9–94.2) 30.1 (17.4–42.8) 3.7 (0.0–8.6)
13. Kolokani 92.2 (90.3–94.0) 76.3 (69.8–82.8) 86.6 (75.8–97.5) 10.2 (1.8–18.7) 0
14. Koulikoro 78.3 (66.8–89.7) 78.1 (74.7–81.4) 99.6 (98.9–100) 19.7 (9.9–29.6) 3.4 (0.0–8.7)
15. Nara 85.7 (83.5–87.9) 86.8 (83.0–90.6) 37.4 (21.9–53.0) 0 10.8 (0.0–23.8)
16. Ouelessebougou 65.4 (54.7–76.2) 57.7 (50.7–64.6) 89.5 (84.6–94.4) 28.8 (16.7–40.8) 0
Region 83.9 (81.6–86.3) 750 (71.8–78.1) 87.2 (84.5–89.9) 19.8 (15.6–24.0) 5.6 (3.5–7.7)
*Examined persons reporting a history of taking azithromycin or using tetracycline ophthalmic ointment during most recent round of mass distribution in 2005 or 2006.
-Data not available.
Parentheses show 95% confidence intervals.
doi:10.1371/journal.pntd.0000734.t004
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need to be built in Kayes and 33,928 in Koulikoro. Building half of
these by 2015 would meet MDG 7c.
Discussion
The national survey conducted in 1997 providing baseline
regional prevalence estimates were very useful in establishing the
widespread nature of trachoma in Mali. In response to results from
the national survey, trachoma control interventions were initiated
in Kayes and Koulikoro Regions. Interventions were focused
mostly on the S and A components of SAFE. F and E interventions
were implemented, but had less geographical coverage of the
target population than S and A. Until 2006, monitoring of
interventions was limited to program reports and did not include
rigorous field evaluations. According to reports of azithromycin
distributed, antibiotic coverage was not consistent between districts
or years with reported district level coverage ranging from 20.9%
to 108.6% after the pilot phase in 2002. Several districts failed to
reach the desired minimum of 80% coverage of total population in
any one year and only one averaged above 80% over three years.
These inconsistencies in coverage were either due to problems
with the distribution or estimates of the target population. For
example, the total population registered prior to MDA may have
exceeded the census estimate of total population where coverage
was greater than 100%. An evaluation of antibiotic distribution in
Southern Sudan demonstrated the limitations of using distribution
reports alone to calculate population coverage, as population
estimates and treatment records can lead to inaccurate coverage
estimates [11]. In Kayes and Koulikoro, we have defined
‘‘distributed’’ as the total number of doses reported to have been
given out to individuals during mass drug administration
campaigns, and caution that they have not been validated with
coverage surveys. The figures are those reported by the district to
the national program.
The first impact assessment in 2006 found prevalence of TF
among children to be below 5% in 9 of 13 districts and below 10%
in all districts. The programmatic decision was made to focus the
available resources to other endemic regions that had not initiated
SAFE interventions. This resulted in stopping mass antibiotic
distribution and limited ongoing promotion of facial cleanliness
and environmental improvements through schools and radio.
Follow-up on the progress of latrine construction and new water
points targeted for trachoma control stopped. Surgical services to
correct trichiasis were maintained. Between the surveys in 2006
and 2009, it appears as though clinical signs of active trachoma
returned in eight out of the thirteen districts.
The current data have several possible interpretations. There
may have been a true decline in active trachoma from baseline to
the present and this decline is associated with interventions from
2003–2006. Although prevalence of active trachoma signs are
higher in some districts now than observed in 2006, the prevalence
remains well below the 34% and 42% TF reported in Koulikoro
and Kayes respectively during the 1997 baseline survey. National
programs do not have control groups and it is not possible to
determine whether the decline is due to the intervention, or to a
Figure 2. Prevalence of blinding trachoma (TT and CO) among women 15 years and older in Kayes and Koulikoro 1997*, 2006 and
2009. *regional estimate from Sche ´mann et al 1998.
doi:10.1371/journal.pntd.0000734.g002
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Prevalence of active trachoma has been observed to decline in the
absence of a trachoma control program in the dessert region of
Kidal [16]. We may also consider that there has been an
heterogeneous effect of the interventions with some districts
showing a sustained reduction in the prevalence of TF (Diema,
Kita, Fana, Kangaba, Nara and Oulessebougou) and others
showing a rapid rebound after initial control (Bafoulabe, Nioro du
Sahel, Banamba, Dioila, Kati, Kolokani and Koulikoro). Such
random effects are assumed possible by chance at the community
level according to a stochastic model of trachoma transmission
[17]. Models also suggest that trachoma endemicity at baseline is
predictive of return of infection after antibiotic intervention [18],
yet we have no district-level estimates at baseline on which to
make assumptions. Antibiotic coverage is an important factor in
the return of infection after treatment and thus the elimination of
trachoma [17,18,19]. It is possible that high-risk marginalized
sections of the population are systematically missed in mass drug
administration leaving them untreated and able to repeatedly
reintroduce infection into treated communities. Coverage surveys
performed immediately following the mass distribution campaigns
at least once during the three years of intervention may have
identified any such problem.
Alternatively, there may be no difference between prevalence
estimates of active trachoma in 2006 and 2009 due to the
differences between the survey methods used and season of
assessment in some districts, although this is unlikely given the
scale of the observed differences and that seasonality of trachoma
in Mali has not been established. In the 2006 survey, household
selection methods may have biased the samples in villages where
only a few large concessions were selected. The starting points
were markets or mosques, structures typically at the center of a
community and often surrounded by more populated concessions.
Some clusters in the 2006 survey were composed of persons
examined from households within a few, very large concessions,
rather than the randomly distributed sample of households
obtained using the sketch mapping and segmentation in the
2009 surveys. The household sampling in 2009 was more similar
to that used in 1997 where a systematic random sample was taken
from a listing of households within clusters. Both evaluations
began with training ophthalmic nurses in the WHO simplified
trachoma grading system. However, in 2009, the grader’s
reliability to diagnose TF was assessed rigorously and nurses not
meeting a certain criteria were excluded from serving as a grader.
This type of field assessment should improve the validity and
reliability of a grader’s findings.
The observed reduction in the prevalence of TT may have been
a direct effect of the ongoing surgical services provided to TT
patients. The diagnosis of TT is straightforward and allows less
room for subjectivity than TF since the grade is based on one or
Figure 3. Prevalence of TF among children less than 10 years of age in Kayes and Koulikoro, Mali 1997*, 2006 and 2009. { estimate
based on surveyed districts. *regional estimate from Sche ´mann et al 1998. **districts not surveyed in 2006.
doi:10.1371/journal.pntd.0000734.g003
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greater than 0.5 mm in diameter in the central part of the tarsal
conjunctiva [3]. The grader’s ability to identify TT is assessed in
the classroom using slides but not in the field reliability assessment
[2]. It may have been possible that graders under diagnosed TT in
the field, but the possibility of this type of misclassification should
not have differed from 2006 and 2009. Additionally, a greater
proportion of adult males were absent from the household than
females. TT impairs vision and thus compromises mobility;
therefore men with healthy eyes may be more likely to be absent
and not examined. Only if the reverse is true, men present in the
household are more likely to have unhealthy eyes, would any bias
in the prevalence of TT in men have masked any gender
difference in TT. In both impact evaluations, women were more
likely to have TT than men, which is consistent with findings from
a recent review on the association of gender and trichiasis [20].
The statistically significant difference observed between TT
prevalence among adults of both genders, but not among adult
females from 2006 to 2009, may suggest a gender disparity in
benefit from ongoing surgical services with men being more likely
than women to present for surgery. Eliminating the backlog of
trichiasis patients needing surgery remains a priority in both
regions. Surgical services may need modification to specifically
target women.
The indicators for A, F and E uptake (Table 4) obtained from
the household surveys have several limitations. Although antibiotic
coverage obtained from personal reports from household residents
appears high, these results should be interpreted with caution.
Residents were asked whether they had taken azithromycin during
the most recent mass distribution campaign, which was in 2006. It
is unlikely that residents could recall specifically taking drugs for
trachoma given that mass drug distribution campaigns for other
NTDs had occurred in more recent years. Additionally, only
responses from residents available to respond were taken. These
residents may have been more likely to have been available to
receive antibiotics during campaigns than those residents absent
from the household at the time of the survey, potentially inflating
the coverage estimate. Not surprisingly, these personal reports are
Table 5. Difference in district-level prevalence estimates of active trachoma signs among children 1–9 years of age in 2006 and
2009 in Kayes and Koulikoro Regions, Mali.
Outcome indicator District Prevalence change
2009–2006
Difference (95% CI) Z value P*
Trachomatous inflammation-follicular (TF)
in children 1–9 years of age
1. Bafoulabe ´ 14.1 (10.6, 17.7) 12.2 ,0.0001
2. Die ´ma 20.6 (23.9, 2.6) 20.62 0.7323
5. Kita 22.7 (25.6, 21.9) 22.77 0.9972
6. Nioro du Sahel 5.8 (3.0, 8.6) 5.37 ,0.0001
8. Banamba 12.0 (7.8, 16.2) 8.8 ,0.0001
9. Dioila 7.3 (5.5, 9.1) 8.2 ,0.0001
10. Fana 1.7 (20.3, 3.6) 2.0 0.0205
11. Kangaba 20.8 (22.6, 1.0) 21.13 0.8698
12. Kati 6.2 (2.3, 9.9) 6.12 ,0.0001
13. Kolokani 8.5 (3.9, 13.2) 7.00 ,0.0001
14. Koulikoro 11.3 (8.9–13.6) 10.62 ,0.0001
15. Nara 20.9 (23.4, 1.5) 21.15 0.8756
16. Ouelessebougou 0.4 (20.7, 1.5) 0.77 0.2220
Trachomatous inflammation-intense (TI)
in children 1–9 years of age
1. Bafoulabe ´ 3.3 (2.1, 4.5) 6.35 ,0.0001
2. Die ´ma 20.5 (22.1, 1.1) 20.83 0.7957
5. Kita 21.1 (22.2, 20.1) 22.18 0.9854
6. Nioro du Sahel 0.2 (20.5, 0.9) 0.65 0.2588
8. Banamba 1.9 (1.0, 2.8) 4.72 ,0.0001
9. Dioila 0.9 (20.2, 1.8) 2.45 0.0072
10. Fana 0.8 (0.0, 1.7) 2.81 0.0025
11. Kangaba 21.2 (22.2, 20.3) 22.24 0.9874
12. Kati 20.1 (20.8, 0.6) 20.30 0.6186
13. Kolokani 20.4 (20.9, 0.1) 21.24 0.8930
14. Koulikoro 0.1 (20.3, 0.5) 0.61 0.2697
15. Nara 20.2 (20.5, 0.0) 21.43 0.9232
16. Ouelessebougou 0.2 (20.3, 0.6) 0.99 0.1616
*Probability that the difference in prevalence 2009–2006 is less than or equal to zero.
doi:10.1371/journal.pntd.0000734.t005
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(Table 2).
More than 75% of households surveyed in each district, except
Nara and Keneiba, had access to a household latrine with
evidence of use. The evidence of use was determined by the
presence of feces in the pit, which may be incorrectly interpreted
as latrine use by all persons within the household. A latrine will be
categorized as ‘in use’ if only a proportion of the household is using
it. The role of latrines in reducing trachoma transmission assumes
that where latrines are used, no open human feces is available for
flies to utilize as a medium for egg and larval development;
reducing successive fly populations and reducing the number of fly
to eye contact. However, if use of a latrine is limited to only certain
groups or if certain groups choose not to use the latrine, open
defecation will continue. Further evaluation may be needed to
assess actual behavior and potentially explain conflicting outcomes
of endemic trachoma in the presence of high sanitation coverage
as seen in Bafoulabe and Banamba districts. Assessing behavior is
also necessary in determining the influence of water on trachoma.
In this survey, there was no association of a clean face and having
access to a water source within the boundaries of the household
compound or having access to a water source outside of village
boundaries. Additionally, greater than 80% of children were
observed to have a clean face in only four districts; indicating that
the practice of face-washing has not been fully accepted and
adopted among residents in the two regions. On the contrary, our
findings may also indicate that the ability of F and E components
to control trachoma may not be as effective as anticipated.
However, a recent analysis of factors associated with active
trachoma in Mali supports the utility of face washing and
environmental improvements [21].
One of the criteria for the certification of the elimination of
trachoma is to demonstrate the sustained reduction of prevalence
of TF among children below 5% for a period of three years after
interventions have ceased [8]. In only six districts did the point
estimate of the prevalence of TF remain below 5% at the district
level from 2006 to 2009. In the 2009 survey the prevalence of TF
among children was above 10% in four districts and above 5% in
another six districts. With the recent global expansion of mass
distribution of antibiotics for trachoma elimination, national
programs may soon face a need to prioritize a limited quantity
of drug [22]. Given such circumstances, Mali is facing unique
programmatic decisions. Currently, WHO guidelines suggest the
district be the implementation unit, but for certification of
elimination, no community must have more than 5% TF among
children [2,9]. This suggests a community-by-community ap-
proach to trachoma elimination even in districts where district-
level estimates of TF prevalence are below 5%. There are no
recommendations or guidelines as to how a country such as Mali
should attempt to demonstrate each and every community
throughout the vast landscape has reached the elimination target.
An acceptable level of TF prevalence at which the risk of
developing blinding trachoma has been eliminated is unknown if
the acceptable level is not zero. TF is not closely correlated with
the presence of Chlamydia trachomatis DNA on ocular swabs and is
thought to linger in the absence of infection [23,24,25,26].
However, TI is better associated with DNA positive ocular swabs
and is also linked to increased likelihood of progression to scarring,
so is considered a more severe form of the disease [23,27]. Ocular
Chlamydia infection may have been significantly reduced by the
interventions as evidenced by prevalence of TI in 9 districts of less
than 1 child per 100. TI is more closely correlated to current
infection with Chlamydia trachomatis than residual TF and has been
suggested as a potential marker of infection post treatment [28]. In
this setting, microbiological supporting evidence of the presence of
bacteria would be useful, yet no guidelines exist for the use of
laboratory diagnostics on a programmatic scale and it is perceived
that costs of adding such tests to impact evaluations are
prohibitive. Using TI for a proxy of infection, the prevalence of
TI in 5 of the 10 districts in Kayes and Koulikoro qualified to
receive mass distribution of antibiotics based on TF, indicates that
less than 1 per 100 children would receive trachoma-specific
benefits from the antibiotic.
Achieving less than 5% TF at the district level is achievable and
can be feasibly determined on a programmatic scale through the
cluster random survey design as demonstrated in this study and in
Ghana [29]. Not considering the differences in survey methodol-
ogy, a district level prevalence of less than 5% TF after three
Figure 4. Prevalence of trachomatous inflammation intense (TI) among children under 10 years of age in Kayes and Koulikoro
1997*, 2006 and 2009. *regional estimate from Sche ´mann et al 1998.
doi:10.1371/journal.pntd.0000734.g004
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all districts to a sustained reduction of TF below 5%. No
surveillance activities were implemented after stopping AFE
interventions in these districts. Doing so may have identified
resurgence in districts with an apparent rebound in active
trachoma and allowed immediate intervention. Results from these
surveys provide evidence in the setting of a national program that
antibiotics alone are not enough to eliminate trachoma. An
analysis of associations between the components of the SAFE
strategy demonstrates clearly that changes in hygiene behavior and
improved sanitation can have protective effects against active
trachoma [30], which argues for equal emphasis on hygiene and
environmental improvements. Indicators used in the 2009 survey
suggest very high access to sanitation in the two regions, but the
indicators fail to capture actual behaviors. The promotion of facial
cleanliness and good hygiene behavior should be reintroduced in
all districts of Kayes and Koulikoro. Surgical services to correct
trichiasis should also be continued, but where and for how long to
continue mass distribution of antibiotics is not as clear. Currently,
the 4 districts with TF above 10% among children are priority for
mass distribution of antibiotics. More guidelines from the
international community are urgently required to help prioritize
the limited quantity of donated antibiotic in addition to
recommending appropriate evaluation methodology for determin-
ing when certification targets have been achieved.
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